science pharmaceutical expo biotech jobs
Originally published online as doi:10.1189/jlb.1002509 on May 22, 2003

Published online before print May 22, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.1002509v1
73/6/722    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peters, M. J.
Right arrow Articles by Klein, N. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peters, M. J.
Right arrow Articles by Klein, N. J.
(Journal of Leukocyte Biology. 2003;73:722-730.)
© 2003 by Society for Leukocyte Biology

Severe meningococcal disease is characterized by early neutrophil but not platelet activation and increased formation and consumption of platelet–neutrophil complexes

M. J. Peters*,{dagger}, R. S. Heyderman{ddagger},§, S. Faust§, G. L. J. Dixon*, D. P. Inwald*,{dagger} and N. J. Klein*

* Infection and Microbiology Unit and
{dagger} Portex Unit Critical Care Group, Institute of Child Health, London, United Kingdom;
{ddagger} Department of Pathology and Microbiology, School of Medical Sciences, University of Bristol, United Kingdom; and
§ Department of Paediatrics, Imperial College School of Medicine (ICSM) at St. Mary’s, London, United Kingdom

Correspondence: Dr. M. J. Peters, Portex Unit Critical Care Group, Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK. E-mail: m.peters{at}ich.ucl.ac.uk

Approximately 25% of polymorphonuclear leukocytes (PMNL) circulate in heterotypic complexes with one or more activated platelets. These platelet–neutrophil complexes (PNC) require platelet CD62P expression for their formation and represent activated subpopulations of both cell types. In this study, we have investigated the presence, time course, and mechanisms of PNC formation in 32 cases of severe pediatric meningococcal disease (MD) requiring intensive care. There were marked early increases in PMNL CD11b/CD18 expression and activation, and reduced CD62L expression compared with intensive care unit control cases. Minimal platelet expression of the active form of {alpha}IIbß3 (GpIIb/IIIa) was seen. PNC were reduced on presentation and fell to very low levels after 24 h. Immunostaining of skin biopsies demonstrated that PNC appear outside the circulation in MD. In vitro studies of anticoagulated whole blood inoculated with Neisseria meningitidis supported these clinical findings with marked increases in PMNL CD11b/CD18 expression and activation but no detectable changes in platelet-activated {alpha}IIbß3 or CD62P expression. In vitro PMNL activation with N. meningitidis (or other agonists) potentiated the formation of PNC in response to platelet activation with adenine diphosphate. Therefore, in severe MD, PMNL activation is likely to promote PNC formation, and we suggest that the reduced levels of PNC seen in established MD reflect rapid loss of PNC from the circulation rather than reduced formation.

Key Words: sepsis • adhesion • meningococcus • inflammation




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
K. Yoshida, R. Kondo, Q. Wang, and C. M. Doerschuk
Neutrophil Cytoskeletal Rearrangements during Capillary Sequestration in Bacterial Pneumonia in Rats
Am. J. Respir. Crit. Care Med., September 15, 2006; 174(6): 689 - 698.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Trujillo and R. R. Kew
Platelet-Derived Thrombospondin-1 Is Necessary for the Vitamin D-Binding Protein (Gc-Globulin) to Function as a Chemotactic Cofactor for C5a
J. Immunol., September 15, 2004; 173(6): 4130 - 4136.
[Abstract] [Full Text] [PDF]